(Q46529547)

English

Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.

scientific article published on 26 May 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15937767

Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000. (English)

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15937767

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Jiehui Li

1

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15937767

Sonal S Munsiff

2

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15937767

Cynthia R Driver

3

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15937767

Judith Sackoff

4

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15937767

language of work or name

0 references

publication date

26 May 2005

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15937767

Clinical Infectious Diseases

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15937767

41

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15937767

83-91

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15937767

1

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15937767

Efficacy and safety of rifabutin in the treatment of patients with newly diagnosed pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1086%2F430377

21 January 2018

A pilot study of antituberculosis combinations comparing rifabutin with rifampicin in the treatment of HIV-1 associated tuberculosis. A single-blind randomized evaluation in Ugandan patients with HIV-1 infection and pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1086%2F430377

21 January 2018

Brief report: rifampin-resistant tuberculosis in a patient receiving rifabutin prophylaxis

1 reference

https://api.crossref.org/works/10.1086%2F430377

21 January 2018

Recurrent tuberculosis in the United States and Canada: relapse or reinfection?

1 reference

https://api.crossref.org/works/10.1086%2F430377

21 January 2018

Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis

1 reference

https://api.crossref.org/works/10.1086%2F430377

21 January 2018

Rifampicin-resistant Mycobacterium tuberculosis.

1 reference

https://api.crossref.org/works/10.1086%2F430377

21 January 2018

Rifampin-monoresistant tuberculosis in New York City, 1993-1994.

1 reference

https://api.crossref.org/works/10.1086%2F430377

21 January 2018

Risk factors for rifampin-monoresistant tuberculosis: A case-control study.

1 reference

https://api.crossref.org/works/10.1086%2F430377

21 January 2018

Risk factors for rifampin mono-resistant tuberculosis.

1 reference

https://api.crossref.org/works/10.1086%2F430377

21 January 2018

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1086%2F430377

21 January 2018

Evaluation of an intensive intermittent-induction regimen and duration of short-course treatment for human immunodeficiency virus-related pulmonary tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clini

1 reference

https://api.crossref.org/works/10.1086%2F430377

21 January 2018

Risk factors for relapse and acquired rifamycin resistance after directly observed tuberculosis treatment: a comparison by HIV serostatus and rifamycin use.

1 reference

https://api.crossref.org/works/10.1086%2F430377

21 January 2018

Six-month supervised intermittent tuberculosis therapy in Haitian patients with and without HIV infection

1 reference

https://api.crossref.org/works/10.1086%2F430377

21 January 2018

HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers

1 reference

https://api.crossref.org/works/10.1086%2F430377

21 January 2018

Relapse in persons treated for drug-susceptible tuberculosis in a population with high coinfection with human immunodeficiency virus in New York City

1 reference

https://api.crossref.org/works/10.1086%2F430377

21 January 2018

Identifiers

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15937767

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15937767

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46529547&oldid=1510770095"